JE

John Mark Ellard

TL Takeda Pharmaceutical Company Limited: 5 patents #285 of 1,531Top 20%
SL Sareum Limited: 2 patents #2 of 8Top 25%
EC Eisai R&D Management Co.: 1 patents #478 of 817Top 60%
ST Shire Human Genetic Therapies: 1 patents #58 of 130Top 45%
📍 Buntingford, GB: #3 of 22 inventorsTop 15%
Overall (All Time): #432,341 of 4,157,543Top 15%
11
Patents All Time

Issued Patents All Time

Showing 1–11 of 11 patents

Patent #TitleCo-InventorsDate
12221441 Plasma kallikrein inhibitors and uses thereof Nikolaos Papaioannou, Jeremy Travins, Sarah Jocelyn Fink, Alastair Rae 2025-02-11
12065448 Heteroaryl plasma kallikrein inhibitors Nikolaos Papaioannou, Jeremy Travins, Sarah Jocelyn Fink, Alastair Rae 2024-08-20
11787796 Plasma Kallikrein inhibitors and uses thereof Nikolaos Papaioannou, Jeremy Travins, Sarah Jocelyn Fink, Alastair Rae 2023-10-17
11370803 Heteroaryl plasma kallikrein inhibitors Nikolaos Papaioannou, Jeremy Travins, Sarah Jocelyn Fink, Alastair Rae 2022-06-28
11352356 Inhibitors of plasma kallikrein and uses thereof Nikolaos Papaioannou, Sarah Jocelyn Fink, Thomas Miller, Gerald W. Shipps, Jr., Jeremy Travins +2 more 2022-06-07
10730874 Inhibitors of plasma kallikrein and uses thereof Nikolaos Papaioannou, Sarah Jocelyn Fink, Thomas Miller, Gerald W. Shipps, Jr., Jeremy Travins +2 more 2020-08-04
10130619 Amido thiadiazole derivatives as NADPH oxidase inhibitors Peter J. Machin, Andrew Sharpe, Christopher James Lock, Mark Stuart Chambers, Alastair James Hodges +1 more 2018-11-20
9187465 Oxazole tyrosine kinase inhibitors John Charles Reader, Helen Boffey, Susanne Taylor, Andrew Carr, Michael Cherry +2 more 2015-11-17
9079914 Fused aminodihydro-oxazine derivatives Christopher Neil Farthing, Adrian Hall 2015-07-14
8921544 Oxazole tyrosine kinase inhibitors John Charles Reader, Helen Boffey, Susanne Taylor, Andrew Carr, Michael Cherry +2 more 2014-12-30
8378095 Oxazole tyrosine kinase inhibitors John Charles Reader, Michael Cherry 2013-02-19